• Home
  • Articles
  • Global News
  • Interest
  • Health Tips
  • Write for Us
    • Contact Us
      • About
      • Privacy Policy

Browse Tag

National OncoVenture

Samsung Biologics, National OncoVenture, and Eutilex obtains IND Approval from FDA
February 11, 2021
Pharmaceutical News/Pharmacy

Samsung Biologics, National OncoVenture, and Eutilex obtains IND Approval from FDA

Samsung Biologics (KRX: 207940.KS) announced another successful Investigational New Drug (IND) clearance from the FDA for its client to begin clinical trials on a cancer immunotherapy, furthering the company’s track record as a premiere CDO service provider in the global market. In late 2018,

More
Samsung Biologics, National OncoVenture, and Eutilex obtains IND Approval from FDA
Pharmaceutical News/Pharmacy

Samsung Biologics, National OncoVenture, and Eutilex obtains IND Approval from FDA

February 11, 2021

Samsung Biologics (KRX: 207940.KS) announced another successful Investigational New Drug (IND) clearance from the FDA for its client to begin

More
  • APAC overview: trends, challenges, and possibilities for growth in the MarTech sector
  • Modernizing Therapeutic Cell Production
  • Neuraxpharm completes its presence in Benelux
  • Pharma Mirror Q&A with Jane Myles, Vice President of Clinical Trial Innovation at Curebase
  • Leg Veins: Why They Appear and How Vein Doctors Treat Them?

© 2010-2022 PharmaMirror.com - All Rights Reserved.

  • Home
  • Articles
  • Global News
  • Interest
  • Health Tips
  • Write for Us
  • Home
  • Articles
  • Global News
  • Interest
  • Health Tips
  • Write for Us
    • Contact Us
      • About
      • Privacy Policy
Go toTop